VahatiCor's Coronary Sinus Reducer (A-FLUX) has been designed to improve angina or angina-like symptoms in patients with CMD. SERRA-I is an early feasibility s…

Angina PectorisMyocardial IschemiaHeart Diseases+3 more

~Estimated

~$10 – $8,750

VahatiCor, Inc.NCT07449325

Phase 2

A Randomized Controlled Study of Targeted Medical Therapy Versus Placebo for Angina and Non- Obstructive Coronary Arteries: The MVP-ANOCA Study

The goal of this clinical trial is to learn if targeted medical therapy will improve symptoms and quality of life in patients with angina and non-obstructive c…

Angina PectorisMicrovascular AnginaVasospastic Angina+1 more

~Estimated

~$10 – $6,250

Stanford UniversityNCT06424834